Supreme Court temporarily restores full access to abortion pill
Key Points:
- The Supreme Court has temporarily blocked a 5th Circuit Court of Appeals decision that would have restricted nationwide access to the abortion pill mifepristone, maintaining the status quo until at least May 11.
- Justice Samuel Alito, overseeing emergency issues from the 5th Circuit, issued the order to allow the Supreme Court time to consider emergency requests from drug manufacturers Danco and GenBioPro.
- The 5th Circuit had ruled to void Biden administration rules permitting mifepristone to be administered without an in-person visit, threatening access especially in states with strict abortion bans.
- Anti-abortion groups argue that in-person dispensing is necessary for safety, despite studies showing mifepristone is safe and effective; drug makers and reproductive health researchers dispute these claims and challenge the legal standing of Louisiana's lawsuit.
- The case centers on the Biden administration’s permanent adoption of COVID-era rules easing access to mifepristone, following the Supreme Court's 2022 decision overturning Roe v. Wade and enabling states to impose abortion restrictions.